Safety and Efficacy Study of GRT6005 in Patients With Osteoarthritis (OA) Knee Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

619

Participants

Timeline

Start Date

December 4, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

April 4, 2014

Conditions
Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee
Interventions
DRUG

Cebranopadol (GRT6005) Low-Dose Range

Capsules

DRUG

Cebranopadol (GRT6005) High-Dose Range

Capsules

DRUG

Placebo

Capsules that did not contain active substance but appeared identical to the cebranopadol and oxycodone CR capsules

DRUG

Oxycodone CR

Capsules containing oxycodone CR 10 or 20 milligrams

Trial Locations (83)

10530

Site 017, Hartsdale

12208

Site 068, Albany

16602

Site 045, Altoona

16635

Site 002, Duncansville

20902

Site 077, Wheaton

21204

Site 088, Towson

23454

Site 026, Virginia Beach

23507

Site 092, Norfolk

27262

Site 006, High Point

27410

Site 056, Greensboro

28401

Site 078, Wilmington

29407

Site 076, Charleston

29621

Site 034, Anderson

30066

Site 052, Marietta

30281

Site 073, Stockbridge

31069

Site 033, Perry

32132

Site 090, Edgewater

32174

Site 025, Ormond Beach

32256

Site 060, Jacksonville

32806

Site 032, Orlando

33028

Site 058, Pembroke Pines

33144

Site 013, Miami

33458

Site 015, Jupiter

33761

Site 071, Clearwater

33781

Site 091, Pinellas Park

34209

Site 011, Bradenton

34238

Site 007, Sarasota

34474

Site 012, Ocala

34652

Site 003, New Port Richey

35209

Site 051, Birmingham

35216

Site 022, Birmingham

35801

Site 031, Huntsville

37620

Site 093, Bristol

43213

Site 001, Columbus

43623

Site 048, Toledo

44122

Site 069, Cleveland

45219

Site 079, Cincinnati

45242

Site 008, Cincinnati

46260

Site 041, Indianapolis

46383

Site 085, Valparaiso

48025

Site 016, Bingham Farms

49684

Site 042, Traverse City

60612

Site 086, Chicago

63141

Site 023, St Louis

68144

Site 074, Omaha

68803

Site 087, Grand Island

73103

Site 075, Oklahoma City

75203

Site 038, Dallas

76309

Site 082, Wichita Falls

77802

Site 049, Bryan

78209

Site 089, San Antonio

78229

Site 040, San Antonio

78731

Site 055, Austin

84020

Site 019, Draper

84106

Site 059, Salt Lake City

84405

Site 064, Ogden

85018

Site 005, Phoenix

85023

Site 018, Phoenix

85027

Site 070, Phoenix

85712

Site 028, Tucson

87102

Site 009, Albuquerque

89130

Site 024, Las Vegas

89144

Site 072, Las Vegas

91361

Site 027, Westlake Village

91606

Site 084, North Hollywood

91710

Site 081, Chino

92020

Site 030, El Cajon

92117

Site 044, San Diego

92780

Site 043, Tustin

93726

Site 061, Fresno

94598

Site 010, Walnut Creek

95628

Site 039, Fair Oaks

95661

Site 080, Roseville

95821

Site 004, Sacramento

97239

Site 035, Portland

97504

Site 067, Medford

97701

Site 029, Bend

98007

Site 066, Bellevue

98057

Site 057, Renton

98122

Site 065, Seattle

02740

Site 083, New Bedford

02747

Site 021, North Dartmouth

01605

Site 020, Worcester

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Forest Laboratories

INDUSTRY

lead

Tris Pharma, Inc.

INDUSTRY